tiprankstipranks
Advertisement
Advertisement

Calumet downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded Calumet (CLMT) to Neutral from Buy with a price target of $36, up from $34. The firm cites valuation for the downgrade following the stock’s outperformance over the last 12 months. Goldman remains constructive on the outlook for renewable diesel margins, but remains selective in its stock selections.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1